For decades, J.D. Power’s research has been a key tool for savvy consumers trying to separate companies with high-quality products and world-class customer service from the other guys.

Clemson defensive tackle DeMonte Capehart has announced his return for a sixth season, providing veteran experience to the Tigers' 2025 defensive line. Capehart's decision follows NCAA approval for an ...

Ross Ulbricht, founder of Silk Road, was convicted in 2015 for operating the online black market and sentenced to life imprisonment. He received a pardon from former U.S. President Donald Trump on ...

Clemson defensive tackle DeMonte Capehart has made it official. The veteran will return to the Tigers for a sixth season. Head coach Dabo Swinney revealed last week that Capehart was waiting on ...

Libertarian and crypto allies of Ross Ulbricht, who was serving a life sentence for distributing drugs on his Silk Road website ... a-Lago to meet with Donald J. Trump. Mr. Trump wanted to ...

Libertarian activists, who generally oppose criminal drug policies, have long believed that government investigators overreached in building their case against Silk Road. Many held “Free Ross” signs. ...

By David Yaffe-Bellany and Ryan Mac President Trump on Tuesday granted a pardon to Ross Ulbricht, the creator of the Silk Road drug marketplace and a cult hero in the cryptocurrency and ...

She is a graduate of Ithaca College and specializes in SEO strategy. Trump, who first proposed to pardon the Silk Road creator during his 2024 presidential campaign, announced his clemency on ...

Clemson received a boost to its D-line group. Tigers defensive tackle DeMonte Capehart is using a waiver for one more season, his sixth, with the Tigers. Capehart played in 11 games with six ...

Dan is a senior editor at Raw Story based in Colorado, producing and editing breaking political news. Dan previously worked as a news associate at The Associated Press in Philadelphia, and later ...

Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...